Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 603Other hematologic neoplasm 439Plasma cell 201Myeloid 200Dermatologic 173Sarcoma 139CNS 59Genitourinary 54Classical hematology 53Gynecologic 47Breast 47Other neoplasm 28Gastrointestinal 9Thoracic 5Head & Neck 4Other solid neoplasm 2Other 1NET 1Endocrine 1

Conditions

Obesity 373Neoplasms 134Breast Neoplasms 95Mucositis 94Overweight 91Sexual Dysfunction, Physiological 90Polycystic Ovary Syndrome 89Dyspnea 56Motor Activity 54Weight Loss 38Constipation 35Diabetes Mellitus 33Prostatic Neoplasms 32Head and Neck Neoplasms 30Colorectal Neoplasms 30Endometrial Neoplasms 26Lung Neoplasms 25Depression 25Diabetes Mellitus, Type 2 23Cardiovascular Diseases 23Multiple Endocrine Neoplasia Type 1 22Pain 20Anxiety Disorders 20Insulin Resistance 19Obesity, Morbid 18Pulmonary Disease, Chronic Obstructive 17Hypertension 17Sexual Dysfunctions, Psychological 16Metabolic Syndrome 16Colonic Neoplasms 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Burkitt Lymphoma × Other × Clear all
NCT05082519 2023-10-26

IDEAL2

Therapeutic Advances in Childhood Leukemia Consortium

Phase 2 Recruiting
240 enrolled
LymphoidOtherOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Obesity, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡